Rigel Pharmaceuticals (RIGL) FCF Margin (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly FCF Margin of 4.63% for Q1 2026, up 631.0% year-over-year from 0.63% in Q1 2025, and down 85.29% quarter-over-quarter from 31.49% in Q4 2025.
Rigel Pharmaceuticals (RIGL) FCF Margin (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' FCF Margin history runs 16 years deep, the most recent figure standing at 4.63% for Q1 2026.
- In Q1 2026, FCF Margin rose 631.0% year-over-year to 4.63%; the TTM figure through Mar 2026 stood at 26.44% (up 892.0% YoY), while the FY2025 annual figure was 25.71%, up 815.0% from the prior year.
- FCF Margin for Q1 2026 stood at 4.63%, down from 31.49% in the prior quarter.
- The five-year high for FCF Margin was 39.2% in Q3 2024, with the low at 154.53% in Q1 2022.
- The 5-year median for FCF Margin is 1.67% (2025), against an average of 9.82%.
- The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 25155 bps in 2022, then jumped 13928 bps in 2023.
- Rigel Pharmaceuticals' FCF Margin stood at 44.56% in 2022, then soared by 61 bps to 17.52% in 2023, then surged by 244 bps to 25.18% in 2024, then climbed by 25 bps to 31.49% in 2025, then slumped by 85 bps to 4.63% in 2026.
- Business Quant data shows RIGL's FCF Margin at 4.63% in Q1 2026, 31.49% in Q4 2025, and 34.6% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 38.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.95% |
| Mar 31, 2026 | 4.63% |
| Dec 31, 2025 | 31.49% |
| Sep 30, 2025 | 34.60% |
| Jun 30, 2025 | 30.03% |
| Mar 31, 2025 | -1.67% |
| Dec 31, 2024 | 25.18% |
| Sep 30, 2024 | 39.20% |
| Jun 30, 2024 | 0.82% |
| Mar 31, 2024 | -16.97% |
| Dec 31, 2023 | -17.52% |
| Sep 30, 2023 | -4.88% |
| Jun 30, 2023 | 22.06% |
| Mar 31, 2023 | -15.25% |
| Dec 31, 2022 | -44.56% |
| Sep 30, 2022 | -56.33% |
| Jun 30, 2022 | -43.18% |
| Mar 31, 2022 | -154.53% |
| Dec 31, 2021 | -91.08% |
| Sep 30, 2021 | -48.59% |